Biodegradable LNG Implant

• User: Female
• Hormonal: Hormonal
• Delivery type:
  • Subdermal
• Intended Duration:
  • Long-Acting
• Development Stage: Pre-Clinical
• Developer(s)/researcher(s): Peking University, Institute of Biomedical Engineering at Chinese Academy of Medical College

Details

• API: Levonorgestrel
• Target: Progesterone Receptor, Androgen Receptor
• Mechanism of Action:
  • Ovulation Inhibition
  • Cervical Mucus Changes
  • Endometrial Changes
• Inactive Materials: PCL/F68
• Regimen: 1 Insertion/Undetermined Interval
• MPT: Not Potential MPT

Product Status

Publications